|
|
|
|
Vol. 17, Issue 6, 2498-2512, June 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Isoform to the Mammalian Trans-Golgi Network


*Department of Cell and Developmental Biology, Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7090; and
Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294-0021
Submitted January 30, 2006;
Revised February 13, 2006;
Accepted March 6, 2006
Monitoring Editor: Reid Gilmore
| ABSTRACT |
|---|
|
|
|---|
localization in mammalian cells. We demonstrate PITP
localizes predominantly to the trans-Golgi network (TGN) and that this localization is independent of the phospholipid-bound state of PITP
. Domain mapping analyses show the targeting information within PITP
consists of three short C-terminal specificity elements and a nonspecific membrane-binding element defined by a small motif consisting of adjacent tryptophan residues (the W202W203 motif). Combination of the specificity elements with the W202W203 motif is necessary and sufficient to generate an efficient TGN-targeting module. Finally, we demonstrate that PITP
association with the TGN is tolerant to a range of missense mutations at residue serine 262, we describe the TGN localization of a novel PITP
isoform with a naturally occurring S262Q polymorphism, and we find no other genetic or pharmacological evidence to support the concept that PITP
localization to the TGN is obligately regulated by conventional protein kinase C (PKC) or the Golgi-localized PKC isoforms
or
. These latter findings are at odds with a previous report that conventional PKC-mediated phosphorylation of residue Ser262 is required for PITP
targeting to Golgi membranes. | INTRODUCTION |
|---|
|
|
|---|
The available evidence indicates confident assignment of function for any individual PITP requires in vivo studies with model genetic systems. The reconstituted systems that show PITP dependence are remarkably promiscuous from the perspective of source of PITP. This is amply demonstrated by the stoichiometric interchangeability of yeast and mammalian PITPs in such reconstitutions (Ohashi et al., 1995
; Cunningham et al., 1996
; Jones et al., 1998
), even though these PITPs exhibit unrelated structural folds (Sha et al., 1998
; Yoder et al., 2001
; Tilley et al., 2004
). By contrast, in vivo studies show even very closely related PITPs play nonredundant functions in cells (Li et al., 2000
; Alb et al., 2002
, 2003
; Routt and Bankaitis, 2004
; Vincent et al., 2005
).
Mammalian cells express three soluble PITPs. PITP
and PITP
share 77 and 95% primary sequence identity and similarity, respectively, and are encoded by distinct genes. The third, rdgB
, is considerably more diverged and remains largely unstudied (Fullwood et al., 1999
). The shared homologies notwithstanding, PITP
and PITP
are functionally distinct (Alb et al., 2002
, 2003
). In this regard, PITP
binds PtdIns and PtdCho, whereas PITP
binds both those phospholipids and, in addition, sphingomyelin (SM; De Vries et al., 1995
). Moreover, recombinant PITP
and PITP
localize to distinct compartments, the former to the cytosol and nucleus and the latter to the cytosol and a perinuclear compartment that is likely the Golgi complex (De Vries et al., 1995
, 1996
; van Tiel et al., 2002
). The relationship between the distinct biochemical properties of these two PITP isoforms and localization and function (if any) remain to be determined.
Herein, we report that endogenous PITP
(and a novel spliceoform thereof) localizes predominantly to TGN membranes and that localization is specified by a functionally redundant set of three short C-terminal motifs. These motifs are collectively insufficient to target a naive reporter to Golgi membranes, but cooperate with a W202W203 motif to generate an efficient TGN-targeting module. We also show that the phospholipid-bound status of PITP
does not contribute to its association with the TGN. Finally, in contrast to a previous claim (van Tiel et al., 2002
), our data indicate that neither localization of PITP
nor its novel spliceoform to Golgi membranes is obligately regulated by conventional protein kinase C (PKC)-mediated phosphorylation of residue serine 262.
| MATERIALS AND METHODS |
|---|
|
|
|---|
/ embryos as previously described (Alb et al., 2003
-mercaptoethanol (for 500 ml of complete medium). Cultures were incubated at 37°C and in 5% CO2. COS-7 cells were transfected using Lipofectamine Plus reagent (Invitrogen, Carlsbad, CA). Briefly, 24 h before transfection the cells were plated at 5060% confluency in six-well plates containing glass coverslips. DNA (1.52 µg) was reconstituted in 100 µl of OptiMEM (Invitrogen), mixed with 2 µl of Plus reagent, and incubated at room temperature for 15 min. In a separate microcentrifuge tube, 3 µl of Lipofectamine was diluted in 100 µl of OptiMEM for each transfection. After 15 min, the solutions were mixed and then incubated for 15 min at 25°C. Cells were washed twice with OptiMEM and incubated at 37°C with DNA mixture in 1 ml OptiMEM for 3 h. Subsequently, 4 ml of complete medium was added, and cells were cultured for 1824 h before processing for immunocytochemistry. MEFs were transfected using the Amaxa (Cologne, Germany) nucleofector following the manufacturer's directions.
Antibody Reagents
PITP antibodies used in this study included: a PITP
isoformspecific rabbit polyclonal antibody directed against the C-terminal 25 amino acid of PITP
(generous gift from Bruce Hamilton), a PITP
isoformspecific chicken polyclonal antibody directed against the last 15 amino acids of PITP
(Alb et al., 2002
), and the NT-PITP-antibody rabbit polyclonal immunoglobulin (Ig) raised against the N-terminus of PITP
and that recognizes both PITP
and PITP
(generous gift of Prof. George Helmkamp, Jr.).
The following primary antibodies were used: a monoclonal antibody directed against actin (Chemicon, Temecula, CA), sheep polyclonal anti-TGN38 Ig (Serotec), monoclonal anti-GM130 antibodies (BD Bioscience, San Diego, CA), and murine monoclonal anti-giantin Ig (generous gift from Dr. Hans Peter Hauri, Switzerland). Secondary antibodies used included: Alexa fluorescein isothiocyanate 488 (Molecular Probes, Eugene, OR), Cy5-conjugated anti-mouse and fluorescein isothiocyanateconjugated anti-mouse (Jackson ImmunoResearch, West Grove, PA), and goat anti-rabbit, goat anti-mouse, or goat anti-chicken horseradish peroxidase (HRP)-conjugated antibodies (Jackson ImmunoResearch).
Immunocytochemistry
Cells were cultured on glass coverslips. Cells were fixed for 15 min with 3.7% formaldehyde in phosphate-buffered saline (PBS), permeabilized in 0.2% Triton X-100 in PBS for 4 min, rinsed once in PBS, and then preincubated for 30 min in blocking buffer (2% BSA in PBS). Permeabilized cells were subsequently incubated with suitable primary antibody appropriately diluted in blocking buffer for 1 h at room temperature, rinsed four times 5 min with PBS, and then incubated with the secondary antibodies appropriately diluted in blocking buffer for 1 h. Cells were rinsed four times in PBS, and coverslips were mounted onto glass slides and examined in a Leica SP2 Laser Scanning Confocal Microscope (Leica, Deerfield, IL). Images were processed with the use of Adobe Photoshop 6.0 (Adobe Systems, Mountain View, CA).
In classifying PITP localization profiles as "Golgi," two major criteria were applied. First, for to score a profile as Golgi the appropriate query profile (GFP or PITP) must exhibit obvious and predominant colocalization with a Golgi marker (TGN38 or GM130). Second, the Golgi component of the query profile must be the strongest signal recorded in the cell being scored. Failure to satisfy both these criteria resulted in a non-Golgi score. Fixed and stained samples were blinded before scoring to control for investigator bias.
Pharmacological Challenge
PITP
/ MEFs were grown on glass coverslips to subconfluency and intoxicated with chelerethryne chloride (0.66 µM; Sigma, St. Louis, MO) or G109203X (10 nM; Sigma) for appropriate times. PKC activity in MEFs was also stimulated by exposure of cells grown on coverslips to PMA (100 nM, Sigma) for 15 min in serum-free medium. Cells were subsequently fixed for PITP
immunostaining as described above. Cell-free extracts were prepared for parallel-treated cultures and processed for immunoblot analysis as described below.
SDS-PAGE and Immunoblotting
Cultures were rinsed with ice-cold PBS and scraped into lysis buffer (20 mM Tris-HCL, pH 7.4, 150 mM NaCl, 2 mM EDTA, 10 mM NaF, 1% Triton 1 mM orthovanadate supplemented with a cocktail of protease inhibitors (Complete; Roche, Indianapolis, IN). For preparation of cell-free extracts, cells (grown to confluency in a 100-mm dish) were incubated with 700 µl of lysis buffer at 4°C for 10 min and then scraped with a rubber policeman into microcentrifuge tubes. After centrifugation at 14,000 x g for 10 min, the supernatant was mixed in Laemmli sample buffer and heated for 5 min at 95°C. Samples were resolved by SDS-PAGE (10%) and transferred to nitrocellulose (Millipore, Billerica, MA). Membranes were blocked overnight at 4°C in TBST (5% dry nonfat milk in 0.05% Tween 20 in Tris-buffered saline) and then incubated for 3 h at room temperature with the appropriate primary antibodies diluted in TBST. Membranes were rinsed four times for 5 min each with TBST and then incubated with the appropriate HRP-conjugated secondary antibody for 1 h, and washed four times for 5 min each with TBST. Blots were developed on x-ray film (Eastman Kodak, Rochester, NY) using the enhanced chemiluminescence (ECL) Western blotting detection reagent (Amersham, Arlington Heights, IL).
Generation of PITP
-GFP and PITP
-GFP cDNAs
PCR primers for rat-PITP
and rat-PITP
cDNA sequences were flanked on the 5' end with the restriction enzyme site HindIII and on the 3' end with the restriction enzyme site BamHI. The HindIII-BamHI PCR fragments were cloned into the pEGFP-C1 plasmid (Clontech, Palo Alto, CA). Yeast plasmids harboring PITP
and PITP
cDNAs (Skinner et al., 1993
) were used as templates in the PCR reactions used for generating the appropriate DNA fragments for cloning. The resulting plasmids were designated pRE772 (PITP
-GFP) and pRE774 (PITP
-GFP). Primer sequences used are available from the authors by request.
Yeast Complementation Assay
Wild-type and mutant PITP
or PITP
-GFP cDNAs, as appropriate, were cloned into the multicopy yeast URA3 vector YEplac195 such that the cDNA was expressed either under control of the powerful constitutive PGK promoter or the constitutively expressed but weaker SEC14 promoter. This expression vector was transformed into the sec14-1ts yeast strain (CTY 1-1A, MATa ura3-52 his3
200, lys2-810 sec14-1ts; Cleves et al., 1991b
) using the lithium acetate method of Ito et al. (1983)
. As matched controls, isogenic vectors with either no insert or with SEC14 or PITP
cDNA inserts were also transformed into the sec14-1ts yeast host strain. Transformants were selected and cultured in uracil-free glucose minimal medium (Sherman et al., 1983
). Five OD600 equivalents of each strain were resuspended in 200 µl Tris-EDTA buffer and serially diluted 10-fold in Tris-EDTA buffer. An aliquot (5 µl) of each dilution was spotted on duplicate YPD agar plates. One plate was incubated at the 30°C (a permissive temperature for sec14-1ts mutants) to report unrestrained growth and viability. The companion plate was incubated at 37°C (normally a restrictive temperature for sec14-1ts mutants) to assess phenotypic rescue of sec14-1ts.
Phospholipid-Transfer Assays
Assays were performed using cytosol prepared from the sec14
cki1 host strain CTY303 expressing the desired PITP as described previously (Kearns et al., 1998
; Phillips et al., 1999
; Li et al., 2000
; Vincent et al., 2005
). Cytosol fractions generated from CTY303 variants expressing Sec14p (positive control) or no PITP (negative control) were generated and assayed in parallel with those fractions containing PITP
, PITP
, or PITP
variants.
Site-directed Mutagenesis
The QuickChange kit (Stratagene, La Jolla, CA) was used. Sequences of the various mutagenic primers used are available from the authors by request. All mutant versions generated were verified by nucleotide sequence analysis.
| RESULTS |
|---|
|
|
|---|
Localizes to the Mammalian Golgi Complex
in mammalian cells relied on microinjection of purified fluorophore-modified protein into cells (De Vries et al., 1996
(van Tiel et al., 2002
localization remain. First, it remains to be demonstrated whether endogenous PITP
is genuinely a Golgi membraneassociated protein. Second, the precise distribution of PITP
within the Golgi stack also remains to be determined.
Specific localization of endogenous PITP
was complicated by our observation that antibodies generated against the extreme C-terminal 15- and 25-residue peptides of these proteins, although facile for distinguishing PITP
from PITP
by immunoblotting, are not satisfactory for immunofluorescence experiments (unpublished data). To circumvent this issue, we used polyclonal antibodies raised against amino-terminal sequences conserved between PITP
and PITP
. These antibodies (NT-PITP-antibody) are suitable for immunofluorescence but are not specific reagents in that these recognize both PITP
and PITP
isoforms in immunoblotting experiments. The specificity issue notwithstanding, we inspected the endogenous PITP immunofluorescence staining profiles obtained with NT-PITP-antibody in an array of cell lines. Swiss 3T3 fibroblasts exhibited a strong perinuclear staining of what appears to be the Golgi apparatus and a diffuse signal in the cytoplasm and the nuclear matrix (Figure 1A). The PITP profiles obtained with Swiss 3T3 cells and NT-PITP-antibody as reporter were typical. Very similar results were also obtained with a variety of other cell lines including astrocytes, primary neurons, and COS-7, HeLa, and HEK293 cells. That the perinuclear PITP staining identifies the Golgi complex is indicated by the coincidence of this profile with that obtained for the cis-Golgi marker GM130 (Figure 1A). As the NT-PITP-antibody immunofluorescence profiles collected with immortalized cell lines represent the sum of endogenous PITP
and PITP
distribution, and previous studies indicate PITP
localizes to the cytoplasm and nuclear matrix (De Vries et al., 1996
), these various localization profiles suggest that endogenous PITP
targets to Golgi membranes in a variety of cell types.
|
in isolation from PITP
, we used NT-PITP-antibody as PITP detector and took advantage of PITP
nullizygous primary cell lines that we had previously generated. The nullizygous MEFs are well suited for these experiments as these cells are phenotypically indistinguishable from wild-type MEFs and retain unadulterated levels of endogenous PITP
(Alb et al., 2002
/ MEFs, and this structure is also stained by the cis-Golgi marker GM130. The GM130 and presumptive PITP
staining profiles are very similar in form, but are not coincident. These data indicate that PITP
does not localize to cis-Golgi membranes but, rather, localizes to a distinct subcompartment of the Golgi complex (see below). Very little staining of the cytoplasm or nucleus is observed, and staining of the lacelike ER is also evident. These staining profiles were absent when naive preimmune serum was substituted for NT-PITP-antibody in these experiments.
To confirm localization of the known PITP
, we constructed a PITP
-GFP chimera, where GFP was fused to the C-terminus of PITP
. The activity of the PITP
-GFP chimera was established with a yeast phenotypic rescue assay. This assay capitalizes on previous demonstrations that high-level expression of mammalian PITPs in yeast rescues the growth and secretory defects associated with inactivation of the essential yeast PITP Sec14p (Skinner et al., 1993
; Tanaka and Hosaka, 1994
). This rescue is dependent on robust PtdIns-binding/transfer by the heterologous mammalian PITP (Alb et al., 1995
). As shown in Figure 1C, a sec14-1ts yeast strain carrying an ectopic copy of the wild-type SEC14 gene grows robustly at 37°C. By contrast, the isogenic sec14-1ts strain fails to grow at all at 37°C, i.e., the restrictive temperature at which the thermolabile sec14-1ts gene product is inactive. Expression of PITP
-GFP restored robust growth to the sec14-1ts yeast mutant at the restrictive 37°C temperature.
The functional PITP
-GFP was expressed in MEFs and the distribution of the chimera was monitored. These localization experiments confirm an unambiguous affinity of PITP
-GFP for Golgi membranes in MEFs (Figure 1D) and also in COS-7 cells (see below).
PITP
Selectively Associates with the TGN
Although both Golgi and ER membranes harbor pools of PITP
, Golgi localization predominates and how PITP
targets to the Golgi membrane system is the focus of this study. To more precisely assign the Golgi subcompartment of residence for endogenous PITP
, we performed a series of double-label immunofluorescence experiments. In these experiments, NT-PITP-antibody was used in combination with compatible antibodies raised against markers for specific Golgi compartments. These markers included GM130 for cis-Golgi, giantin for cis- and medial-Golgi, and TGN38 for the TGN. PITP
nullizygous MEFs were used to ensure specific detection of endogenous forms of PITP
.
As shown in Figures 2, A and B, endogenous PITP
exhibits little coincidence of staining with the cis-Golgi marker GM130, or the medial-Golgi marker giantin, even though the general profiles for PITP
and these markers are very similar. Endogenous PITP
species exhibit a higher degree of colocalization with the trans-Golgi membrane marker TGN38, however (Figure 2C). The predominant localization of PITP
to TGN membranes is emphasized in a stereo reconstruction of the MEF Golgi apparatus generated from triple-label experiments monitoring PITP, giantin, and TGN38 (Supplemental Video, Figure S1). The rotating image distinguishes giantin staining from the yellow staining that reports colocalization of TGN38 and PITP
. We infer from these experiments that PITP
targets predominantly to the trans-aspect of the Golgi stack in MEFs.
|
spliceoform (referred to as PITP
QGQR, as opposed to canonical spliceoform that we refer to as PITP
) that is invisible to our PITP
-specific antibodies in immunoblot experiments (murine form, accession number AAH34676; rat form, AAH61538; human form, AAH31427). This spliceoform is detected by the NT-PITP-antibody, however, and the PITP
localization profiles described in Figure 2 represent the sum of the PITP
and PITP
QGQR profiles (these two spliceoforms are both expressed in MEFs; unpublished data). Defined GFP-chimeras permit localization of each spliceoform in isolation, however. As further described below, we show that both PITP
-GFP and PITP
QGQR-GFP reporters target efficiently to similar (albeit not identical) Golgi subcompartments.
PITP
C-terminal Motifs Necessary for TGN Targeting
The distinctive localization profiles for PITP
and PITP
are remarkable in light of the high degree of primary sequence identity shared by these PITPs. To map the determinants specifying targeting of PITP
to the mammalian TGN in an unbiased manner, we constructed a reciprocal series of PITP
/PITP
hybrid proteins in the context of a functional PITP-GFP chimera. The functional status of key chimeras was confirmed in the heterologous yeast sec14-1ts phenotypic rescue assay (Skinner et al., 1993
; described above and in Figure 1C). All chimeras generated were active in the yeast phenotypic rescue assay and were expressed both in PITP
/ MEFs and in COS-7 cells. The respective intracellular distributions were imaged and quantified for both cell types. In describing the results of the mapping experiments, we present data obtained with MEFs and report the COS-7 data in Supplemental Materials.
The C-terminal 28 PITP
residues are both necessary for PITP
targeting to Golgi membranes and are sufficient to efficiently redirect PITP
to that location (Figure 3A). The results were robust because the incidence of Golgi targeting in cells was >90% for PITP
and the PITP
/
chimera and <5% for PITP
and the PITP
/
chimera. Representative images for each chimera are shown in Figure 3B. In the imaging experiments reported herein, we typically identify the Golgi region by surveying the cis-Golgi marker GM130 but confirmed that assignment by costaining with the pan-Golgi marker wheat germ agglutinin and, for key reporter/mutant constructs, by costaining for TGN38 (see below).
|
and PITP
C-terminal primary sequences identifies three motifs of greatest divergence between these isoforms. We refer to these motifs as BOX1, BOX2, and BOX3 (Figure 3C). Mutagenesis experiments, where each individual BOX region from PITP
was substituted for the corresponding BOX region of PITP
, demonstrated that PITP
KQE, PITP
QDPK, and PITP
MTD all exhibited efficiencies of Golgi localization similar to those recorded for the PITP
control (Figure 3, C and D). Thus, no single BOX motif is essential for PITP
targeting to Golgi membranes. We also observed that swap of any two of the BOX domains from PITP
into the PITP
context did not compromise association of PITP
with TGN membranes (Figure 3, C and D). These data indicate that the presence of any single PITP
motif is sufficient for maintenance of PITP
localization to the Golgi complex. Parallel analyses of the localization properties of each chimera were also conducted in COS-7 cells with essentially identical results (Supplemental Materials, Figure S2).
PITP
C-terminal Motifs Sufficient for Targeting PITP
to Golgi Membranes
To address the dual criteria of necessity and sufficiency, we tested whether any BOX residues sufficient for PITP
localization to the TGN were capable of redirecting PITP
to the same. To this end, PITP
BOX1 or BOX3 residues were incorporated into the context of an otherwise wild-type PITP
. The localization profiles of both constructs (PITP
QET and PITP
TSA) fully recapitulated the nuclear and cytoplasmic distribution of the PITP
control (Figure 4A). Thus, neither BOX1 nor BOX3 has an assignable targeting function on its own in the context of PITP
. However, BOX2 residues, although dispensable for PITP
targeting to the Golgi complex, increased the efficiency with which an otherwise wild-type PITP
reporter associates with Golgi membranes. That construct (PITP
KGSR) was scored as targeting to Golgi membranes in 51% of the transfected cells analyzed. Although this level of targeting is not as robust as that observed with the PITP
positive control (>90%), it is substantial when compared with the basal association of the PITP
control with the Golgi complex (ca. 5%; Figure 4A).
|
BOX motifs were swapped into the PITP
context, an essentially complete redirection of a PITP
reporter to the TGN was observed. Combinatorial incorporation of PITP
BOX1 and BOX2 residues, BOX1 and BOX3 residues, or BOX2 and BOX3 residues into the PITP
context yielded chimeras that efficiently targeted to Golgi membranes (Figures 4, A and B). For reasons detailed below, we were particularly interested in any role BOX2 or its individual residues may play in the localization of PITP
to the TGN. In that regard, the dispensability of BOX2 residues for PITP
Golgi targeting was further emphasized in a swap of BOX2 from PITP
for the PITP
BOX2 in the context of a PITP
chimera that harbors the C-terminal 28 PITP
residues. This PITP
QET-TSA chimera is composed entirely of PITP
primary sequence, save 24 of 28 C-terminal residues where the PITP
BOX2 motif is substituted for that of PITP
. Yet, PITP
QET-TSA retains its capacity to target to Golgi membranes (Figures 4, A and B). Again, these conclusions were confirmed when these same chimeras were expressed in COS-7 cells and the corresponding localization profiles were scored (Supplemental Materials, Figure S3). The data indicate that the combination of any two of the PITP
BOX motifs is sufficient to generate a robust Golgi localization signal in the context of PITP
.
PITP
Ser262 Is Nonessential for Golgi Localization
The dispensability of BOX2 for PITP
localization to TGN membranes was counter to the findings of van Tiel et al. (2002)
, who reported that phosphorylation of a BOX2 residue (S262) is essential for PITP
targeting to Golgi membranes. Yet, our demonstration that swap of PITP
BOX2 residues significantly improved PITP
targeting to Golgi membranes (i.e., the PITP
KGSR construct; Figure 4A) is consistent with a more substantial role for BOX2 in Golgi targeting. To investigate these paradoxical findings in more detail, we analyzed the involvement of S262 itself in PITP
localization. Consistent with the results of the BOX2 chimera experiments, PITP
S262A, PITP
S262D, PITP
S262E, and PITP
S262P all targeted to Golgi membranes as efficiently as the PITP
control (Figure 4C). These results were recapitulated in the context of COS-7 cells (Supplemental Figures and Supplemental Table S1).
To determine whether an analogous phosphorylation may be sufficient to redirect PITP
to Golgi membranes, we incorporated phosphomimetic amino acids at the corresponding P263 residue of PITP
to generate the PITP
P263D and PITP
P263E mutants. The ability of each to associate with MEF TGN membranes was then assessed. Neither PITP
P263D nor PITP
P263E targeted to Golgi membranes any more efficiently than the PITP
control (Figure 4D). We repeated these analyses in COS-7 cells. Again, neither incorporation of the P263S missense substitution, nor P263E, into the context of PITP
-GFP had any major effect on the intracellular distribution of the chimera (Supplemental Materials, Supplemental Table S1).
A Novel PITP
Isoform with Altered BOX2 Residues Targets to the TGN
All of the experiments described above rely on mutagenesis of canonical PITP
. The novel murine PITP
spliceoform described above (PITP
QGQR) differs from canonical PITP
predominantly in BOX2 (Figure 4E). Interestingly, S262 of canonical PITP
is Q262 in PITP
QGQR. PCR assays indicate both PITP
and PITP
QGQR are expressed in PITP
/ MEFs at approximately equal levels.
Localization experiments using GFP-tagged forms show PITP
QGQR, like PITP
, associates with MEF Golgi membranes (Figure 4E). These results are consistent with data indicating S262 is nonessential for efficient targeting of PITP
species to that compartment. PITP
QGQR displays a single nonconserved serine residue (S259) in the region of divergence, but the S259A mutation has no effect on targeting of a PITP
QGQR-GFP chimera to TGN membranes (Figure 4E). These data lead us to form two conclusions in addition to S262 dispensability for PITP
targeting to Golgi. First, S259 does not offer an alternative phosphorylation site required for PITP
QGQR association with Golgi membranes. Second, mammalian cells can express more than one PITP
species in cells but, in this case, both PITP
and PITP
QGQR isoforms home to Golgi membranes. Comparison of the localization profiles of PITP
-GFP and PITP
QGQR-GFP chimeras indicates both target to the TGN, although PITP
QGQR-GFP also exhibits partial colocalization with the medial-Golgi marker mannosidase II (Supplemental Materials, Figure S4, A and B). PITP
QGQR-GFP also appears to target more efficiently to cis-Golgi membranes than does PITP
-GFP (Supplemental Materials, Figure S4C). Thus, PITP
QGQR may represent more of a pan-Golgi PITP
than the canonical PITP
.
PITP
Targeting to Golgi Membranes Is Independent of PtdIns- or SM-Transfer Activity
As described in detail below, the C-terminal 28 PITP
residues are sufficient to redirect PITP
to Golgi membranes but are insufficient to target a naive protein to this intracellular location. These data suggest that multiple localization signals may be involved in localizing PITP
to the TGN and that a subset of these determinants likely resides in the PITP domain itself. As PITP domains represent specific lipid-binding modules, PITP
lipid-binding properties themselves could potentially define components of a combinatorial targeting signal.
To test this possibility, we took advantage of mutant PITP
derivatives with selective defects in the loading/transfer of defined phospholipid substrates. Given that PITP
is distinguished from PITP
in its ability to bind SM in addition to PtdIns and PtdCho, one attractive possibility is that SM loading contributes to the affinity of PITP
for Golgi membranes. Data obtained from three independent lines of experimentation demonstrate that SM-loading and Golgi targeting are not strictly coupled. First, wholesale swap of the PITP
C-terminal 28 residues into the context of PITP
leads to a PITP chimera that fails to associate with the Golgi complex (see Figure 3, A and B above). Yet, this PITP
/
chimera exhibits robust SM transfer in vitro (Figure 5A). Second, reciprocal swap of the PITP
C-terminal 28 residues into the context of PITP
results in a hybrid PITP
/
that efficiently targets to the Golgi complex (see Figure 3, A and B above). This PITP
/
chimera, while elaborating both PtdIns- and PtdCho- transfer activity, exhibits no detectable SM-loading/transfer activity in vitro (Figure 5A). Third, substitution of only two amino acids in PITP
to the cognate PITP
residues is sufficient to confer robust SM-transfer activity to PITP
(PITP
LF221,225IL; Figure 5A). Reciprocally, conversion of those cognate PITP
residues to the corresponding PITP
residues strongly and specifically compromises the SM-transfer activity of PITP
(PITP
IL220,224LF; Figure 5A). In neither case does modulation of SM-loading/transfer affect PtdIns- or PtdCh-transfer activity or PITP localization. PITP
IL220,224LF fully retains the ability to target efficiently to Golgi membranes, whereas PITP
LF221,225IL does not (Figure 5B).
|
to the TGN, we took advantage of mutants specifically defective in PtdIns-binding/transfer activity. PITP
residue T59 is essential for PtdIns-binding/transfer, but plays no role in PtdCho-binding/transfer (Alb et al., 1995
context as biochemical analyses confirmed that the corresponding PITP
mutant (PITP
T58D) retains high levels of both PtdCho- and SM-transfer activity in the absence of measurable PtdIns-transfer activity (unpublished data). We constructed the PITP
T58D-GFP chimera and assessed its subcellular distribution in PITP
/ MEFs. Imaging experiments show ca. 90% of the cells expressing PITP
T58D-GFP exhibited robust Golgi staining profiles, a score recapitulating that of the PITP
control (Figure 5C). When the experiment was performed in COS-7 cells, PITP
T58D-GFP assumed an obvious Golgi localization in 91% of the 99 expressing cells imaged (90 Golgi/9 non-Golgi profiles). Thus, PtdIns-loading/transfer does not contribute to PITP
targeting to Golgi membranes.
Uncoupling of Phospholipid-Transfer Activity from PITP
Targeting to Golgi Membranes
Although neither PtdIns- or SM-loading/transfer activity are required for PITP
association with the TGN, a combination of phospholipid-loading/transfer activities could contribute to such targeting. We therefore tested whether residue Ser165 is required for targeting of PITP
to the Golgi complex. This residue lies in the PITP regulatory loop (Yoder et al., 2001
). The side-chain status of this residue is functionally important because incorporation of either alanine or glutamate at this position abolishes all PITP
phospholipid-transfer activities (van Tiel et al., 2000
).
The PITP
S165A mutant was generated and its biochemical properties were assayed in vitro. As reported by van Tiel et al. (2000)
for PITP
S166A, we too find PITP
S165A exhibited no measurable PtdIns-, PtdCho-, or SM-transfer activity, even though full-length PITP
was readily detected in the cytosolic fractions by immunoblot (unpublished data). The S165A missense substitution had no effect on PITP
localization when assayed in PITP
/ MEFs. PITP
S165A-GFP was targeted as efficiently to Golgi membranes as the PITP
-GFP control (Figure 5D). Because PITP
S165A exhibits no detectable phospholipid-transfer activity, PITP
S165A-GFP association with Golgi membranes is independent of phospholipid-transfer activity.
We also expressed PITP
S165,262A-GFP in PITP
/ MEFs and assessed the ability of this double mutant to target to TGN membranes. This experiment was motivated by the demonstration that PITP
residue S166 and PITP
residue S165 are minor PKC phosphorylation sites (van Tiel et al., 2000
, 2002
). PITP
S165,262A is therefore devoid of the PKC phosphorylation sites for which there is any evidence of use. Yet, PITP
S165,262A-GFP homes to TGN membranes in PITP
/ MEFs (Figure 5D). These data provide further support for our conclusion that PKC-mediated phosphorylation of PITP
(at least on the presently known S165 and S262 sites) does not play an essential role in localization of this protein to mammalian TGN membranes.
A WW Motif Common to PITP
and PITP
Contributes to Association of PITP
with TGN Membranes
PITP
occupied with either PtdCho or PtdIns crystallizes as a dimer, and the dimerization interface is defined by two small hydrophobic motifs displayed on exposed loops of the PITP fold (Figure 6A; Yoder et al., 2001
; Tilley et al., 2004
). These two motifs are represented by 72FVRML76 and W203W204 of PITP
and 71FVRMI75 and W202W203 of PITP
, respectively, and both are suggested to play critical roles in mediating membrane binding by PITP
(Schouten et al., 2002
; Tilley et al., 2004
). To test whether 71FVRMI75 or W202W203 contribute to localization of PITP
to the murine TGN, we mutagenized these motifs in the context of a PITP
-GFP reporter and analyzed localization of the corresponding reporters in PITP
/ MEFs. The comprehensive data are quantified in Figure 6B, and representative imaging profiles for the corresponding mutant PITP
forms are given in Figure 6C.
|
WW202,203AA-GFP chimera failed to associate stably with PITP
/ MEF TGN membranes. By contrast, PITP
MI74,75AA-GFP retained near wild-type efficiencies for TGN targeting (Figure 6, B and C). Although there is a consistent diminution in TGN association for the PITP
MI74,75AA-GFP chimera, the defect is minor. Essentially the same results were obtained with PITP
F71A-GFP and PITP
VR72,73AA-GFP chimeras. By contrast, the individual W202 and W203 residues each play important roles in localization of PITP
, as evidenced by the obvious defects in PITP
W202A-GFP and PITP
W203A-GFP association with MEF TGN membranes (Figure 6B).
Previous data obtained from PtdIns loading assays performed with permeabilized cells indicated PITP
WW202,203AA is strongly defective in PtdIns loading and is incompetent for the membrane interaction step of a phospholipid-transfer reaction (Tilley et al., 2004
). We obtained two lines of evidence that are not congruent with this conclusion, at least in the PITP
context. First, biochemical assays for phospholipid-transfer activity demonstrate PITP
MI74,75AA and PITP
WW202,203AA exhibit significant levels of PtdIns-, PtdCho-, and SM-transfer activity in vitro (Figure 7A). Second, we again took advantage of the yeast phenotypic rescue assay described above to independently assess whether the phospholipid-binding/transfer activities of the double mutant PITPs were strongly compromised. The results from that rescue assay also support the conclusion that both PITP
MI74,75AA and PITP
WW202,203AA are substantially functional proteins. As shown in Figure 7B, a wild-type yeast strain grows robustly at 30 and 37°C. By contrast, an isogenic sec14-1ts strain grows only at the permissive temperature of 30°C and not at all at the restrictive temperature of 37°C, i.e., the temperature at which the thermolabile sec14-1ts gene product is inactive. PITP
expression from either a strong constitutive promoter (PPGK) or a weaker constitutive promoter (PSEC14) restored essentially wild-type growth properties to the sec14-1ts yeast mutant. Similarly, expression of either PITP
MI74,75AA or PITP
WW202,203AA from the PPGK driver also supported efficient rescue of sec14-1ts-associated growth defects at 37°C (Figure 7B). Rescue mediated by both mutant PITP
forms was also recorded when the mutant proteins were expressed from the weaker PSEC14 promoter, although quality of rescue was diminished slightly under those conditions for PITP
WW202,203AA (Figure 7B).
|
MI74,75AA nor PITP
WW202,203AA exhibit dramatic defects in phospholipid-transfer activity and phospholipid loading. Because these various double mutant PITPs retain phospholipid-transfer activity, the PITP fold must remain unperturbed in the double mutants. We conclude that the TGN localization defects associated with mutation of W202W203 cannot be simply ascribed to a wholesale inability of PITP
to interact with membranes.
PITP
Motifs Sufficient for Redirection of GFP to the TGN
The collective data suggest it is the combination of weak membrane targeting/association signals defined by the C-terminal BOX residues and the W202W203 motif that specifies PITP
association with TGN membranes. To test this prediction we fused the C-terminal 35 and 71 residues of PITP
to the GFP C-terminus. The former chimera (GFP-PITP
237271) elaborates all three of the C-terminal BOX motifs, is predicted to preserve the C-terminal PITP
helix, but lacks both the W202W203 motif and obviously lacks an intact PITP fold. The latter chimera (GFP-PITP
201271) elaborates both W202W203 and the three BOX motifs, is predicted to maintain the ultimate two PITP
helices, but lacks an intact PITP fold. The chimeras were expressed in PITP
/ MEFs and their respective intracellular distributions were determined.
As expected, the GFP control distributes to the cytoplasm and nuclear matrix and fails to associate with Golgi membranes as evidenced by its lack of colocalization with the TGN marker TGN38 (Figure 8). This profile was recapitulated for the GFP-PITP
237271 chimera that harbors all three of the C-terminal BOX motifs but no W202W203 motif. By contrast, GFP-PITP
201271 targeted efficiently to PITP
/ MEF TGN as demonstrated by its colocalization with TGN38-positive structures (Figure 8). Some 85% of the cells showed coincident localization of GFP-PITP
201271 with the TGN. Thus, linking the PITP
W202W203 motif with the three BOX motifs generated a targeting module that satisfies the dual criteria of necessity and sufficiency for specific association with TGN membranes.
|
Association with TGN Membranes and Action of PKCs
association with the Golgi complex depends on conventional PKC-mediated phosphorylation of S262 (van Tiel et al., 2002
to the TGN. As a first approach, we applied a blunt pharmacological strategy. PITP
/ MEFs were intoxicated with two different inhibitors of conventional PKCs, and PITP
distribution of was monitored at various times postchallenge. Neither GF109203X nor chelerythrine chloride intoxication had any effect, at any time, on the association of PITP
with the MEF TGN (Figures 9, A and B). The efficacy of pharmacological challenge in inhibiting PKC activity was confirmed by monitoring phospho-MARCKS upon inhibitor challenge (Figure 9C).
|
and PITP
QGQR in those experiments. We therefore repeated these experiments using a PITP-GFP reporter and arrived at the same conclusions. PITP